Clinical Trial

Multimodal Biomarkers in Prediction of Diabetic Retinopathy

Study acronym: ZOCDR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to enroll diabetic patients with diabetic retinopathy and those without diabetic retinopathy, follow up and observe the long-term changes in ocular structure and function of the subjects by comparison, analyze their association with multimodal biomarkers, and explore new methods for the early diagnosis and risk prediction of diabetic retinopathy. Participants will be followed up over a 5-year follow-up period, during which they will undergo ophthalmic examinations, blood tests, and questionnaires.
Trial Details
NCT Number NCT07098832
Lead Sponsor Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions Diabetic Retinopathy (DR)
Enrollment 1,538 participants
Start Date 2025-07
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-01